
Carl Zeiss Meditec Ag
(ETR) AFX
Carl Zeiss Meditec Ag Financials at a Glance
Market Cap
€2.17B
Revenue (TTM)
€2.73B
Net Income (TTM)
€140.19M
EPS (TTM)
€1.08
P/E Ratio
22.92
Dividend
€0.55
Beta (Volatility)
0.00 (Low)
Dividend
€0.55
Beta (Volatility)
0.00 (Low)
Price
€24.94
Volume
240,872
Open
€24.76
Price
€24.94
Volume
240,872
Open
€24.76
Previous Close
€24.94
Daily Range
€24.48 - €25.04
52-Week Range
€22.62 - €58.75
Estimated Earnings Date
Aug 6, 2026
Dividend
€0.55
Beta (Volatility)
0.00 (Low)
Price
€24.94
Volume
240,872
Open
€24.76
Previous Close
€24.94
Daily Range
€24.48 - €25.04
52-Week Range
€22.62 - €58.75
Estimated Earnings Date
Aug 6, 2026
AFX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Carl Zeiss Meditec Ag
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
5,784
CEO
Maximilian Foerst
Website
www.zeiss.deHeadquarters
Jena, 07745, DE
AFX Financials
Key Financial Metrics (TTM)
Gross Margin
52%
Operating Margin
9%
Net Income Margin
5%
Return on Equity
5%
Return on Capital
8%
Return on Assets
4%
Earnings Yield
4.36%
Dividend Yield
2.21%
Payout Ratio
71.81%
Stock Overview
Market Cap
€2.17B
Shares Outstanding
87.54M
Volume
240.87K
Avg. Volume
230.40K
Financials (TTM)
Gross Profit
€1.18B
Operating Income
€223.32M
EBITDA
€346.89M
Operating Cash Flow
€209.86M
Capital Expenditure
-€39.39M
Free Cash Flow
€170.46M
Cash & ST Invst.
€27.27M
Total Debt
€607.37M
Carl Zeiss Meditec Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
€990.98M
+102.0%
Gross Profit
€490.52M
+94.6%
Gross Margin
49.50%
N/A
Market Cap
€2.17B
N/A
Market Cap/Employee
€1.05M
N/A
Employees
2,066
N/A
Net Income
€14.67M
-6.6%
EBITDA
€113.46M
+320.2%
Quarterly Fundamentals
Total Cash
€23.90M
+17.8%
Total Debt
€617.56M
N/A
Accounts Receivable
€623.70M
N/A
Inventory
€538.55M
N/A
Long Term Debt
€557.73M
N/A
Short Term Debt
€59.82M
N/A
Return on Assets
4.20%
N/A
Return on Invested Capital
8.21%
N/A
Free Cash Flow
€88.86M
+437.9%
Operating Cash Flow
€98.92M
+476.1%